Illness	Number of cases
Volume depletion (E86)	184
Cystitis (N30.0)	136
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	132
Pneumonia organism unspecified - Lobar pneumonia unspecified organism (J18.1)	131
Other septicaemia - Sepsis unspecified organism (A41.9)	98
Other and unspecified infectious diseases (B99)	96
Chronic obstructive pulmonary disease with acute exacerbation (J44.10)	90
Other diseases of digestive system - Gastrointestinal hemorrhage unspecified (K92.2)	88
Acute kidney failure unspecified (N17.93)	83
Erysipelas (A46)	82

Top 10 treatments

Treatment	Number
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	974
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	783
(9-984.7)	697
Computed tomography of the abdomen with contrast medium (3-225)	672
Computed tomography (CT) of the head without contrast medium (3-200)	665
Computed tomography of the chest with contrast medium (3-222)	601
(9-984.8)	458
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	388
Examination of the trachea and the bronchi by endoscopy (1-620.00)	368
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	324

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
147	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
125	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
68	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)	Die Sana Kliniken Lübeck sind akademisches Lehrkrankenhaus der Universitätsklinik Schleswig-Holstein.
Lectureships / teaching posts at universities of applied sciences	Die Sana Kliniken Lübeck sind Lehrkrankenhaus der Universität zu Lübeck und beteiligen sich an der Ausbildung von Medizinstudierenden im Rahmen von Untersuchungskursen, Famulaturen und dem Praktischen Jahr. Die praktische Ausbildung erfolgt unter Supervision von Assistenz- und Oberärzten.
Project-related cooperation with colleges and universities	Mit dem UKSH: Herzchirurgie, Kardiologie zur Betreuung von Aortenklappenstenosen, Arbeitsgruppe CED (chronisch-entzündliche Darmerkrankungen). Mit dem UKE-Kardiologie zur Elektrophysiologie und mit dem Herzzentrum Dresden (Uniklinik, Elektrophysiologie)
Lectureships / teaching posts at colleges and universities
Doctoral supervision	Unter anderem Betreuung von Bachelor- und Masterstudierenden (Fachhochschule Flensburg, Technische Hochschule Lübeck, Fachhochschule Osnabrück).
Participation in multi-centre phase III/IV studies
Participation in multi-centre Phase I/II studies